The importance of aeronautics and aerospace to the Swiss economy deserves to be underlined. Increasing regulation at European level is constantly presenting the entire sector with major new challenges that can only be met through innovative product and process improvements.
Adequate Swiss supports numerous clients in Switzerland to enable them to meet the strong demand from international markets. We take on complete cabin modification projects, for the VIP and business jet sector as well as for MROs.
For years, the pharmaceutical industry has been Switzerland’s main engine of industrial growth, making a decisive contribution to overall economic growth.
The Life Sciences sector is evolving rapidly through diversification, restructuring and acquisitions. Aware of the complex challenges facing our clients, Adequate Swiss Sarl offers consulting and engineering services in the field of life sciences.
Adequate Swiss assists major players in the chemical, pharmaceutical and biotechnology process industries. Together, we help them develop their products so that their vision becomes reality.
The Swiss medical technology industry is facing challenges related to ever changing global regulation, but remains robust thanks to the commitment of its companies. Despite this, it continues to grow, creating 4,500 new jobs over the last two years and generating sales of 20.8 billion Swiss francs by 2021. The COVID-19 pandemic has had different impacts on different sectors, with some experiencing strong growth while others have been limited.
The Industry makes a positive contribution to Switzerland’s balance of trade, with a surplus of CHF 5.9 billion in 2021, and the EU remains its main trading partner. Swiss companies have prepared themselves for the regulatory challenges, enabling them to meet the additional export requirements to continue to be a global player. In summary, despite the challenges, the Swiss medtech industry is showing notable resilience thanks to the commitment and adaptability of its participants.
Adequate Swiss is committed to supporting the leaders of the medical device industry. We work hand in hand with them to realise their vision by developing innovative products.
Switzerland’s largest industrial employer, the machinery and industrial equipment sector accounts for over 7% of the country’s GDP and 30% of its exports. Made in Switzerland is particularly well known in this segment. R&D is undoubtedly a key component of the Swiss economy, with 3% of GDP invested in research and development annually.
This industry experienced a particularly robust recovery after the health crisis, and is now reporting a 10.4% increase in sales between 2020 and 2021. Exports grew by 12.7% over the same period.
Adequate Swiss helps to support Swiss industrial companies with their projects in Switzerland and abroad.
Route des falaises 7
2000 Neuchâtel Suisse
Tel.: +41 (0)78 835 05 91